Google DeepMind has broken apart the team that won a Nobel Prize for solving the 50-year protein-folding problem, reassigning most original AlphaFold researchers and losing key talent to rival Anthropic. The lab is reorganizing around large language models like Gemini instead of maintaining dedicated teams focused on singular scientific breakthroughs.

Why Is DeepMind Dismantling Its Most Celebrated Team?

AlphaFold represented DeepMind's core strategy for nearly a decade: assemble world-class researchers, point them at one hard problem, and solve it. The team cracked protein folding, predicting 3D protein shapes in minutes, a breakthrough that now underpins drug discovery and disease research worldwide. Less than a year after Demis Hassabis, DeepMind's chief, shared the 2024 Nobel Prize for this work, the lab has reassigned most of the original AlphaFold paper authors over the past year, with nearly a quarter leaving the company entirely.

DeepMind confirmed the moves and is folding the work into a wider push around Gemini, its large language model. The lab's research vice president explained the rationale: "Our strategy over the last nine years has been to focus on grand challenges. The strategy has evolved," according to Pushmeet Kohli. Instead of one team per problem, DeepMind is now building Gemini-powered systems meant to assist scientists and automate parts of research itself.

Where Did the AlphaFold Researchers Go?

The exodus reveals the competitive pressure in AI talent markets. Former AlphaFold staff have scattered across multiple destinations. Some moved to Gemini projects, others to enzyme design, nuclear fusion, and genomics work within DeepMind. A few joined Isomorphic Labs, the Alphabet drug-discovery spinout that AlphaFold itself inspired.

The most significant losses walked out entirely. John Jumper, who shared the 2024 Nobel with Hassabis, left for Anthropic in June. Two core AlphaFold researchers, Jonas Adler and Alexander Pritzel, followed him to the same rival. One DeepMind employee told the Financial Times that these three were "instrumental, important, core members" whose exits "sparked surprise internally." They are now at Anthropic, which just launched Claude Science, a workbench built for the exact biology and drug-discovery work AlphaFold pioneered.

How to Understand DeepMind's Strategic Shift

• From Focused Science to Broad AI: DeepMind's nine-year strategy of assembling dedicated teams for singular problems is being replaced by a model centered on large language models like Gemini that aim to assist across multiple scientific domains.
• Talent Migration to Rivals: Key researchers are departing to Anthropic and other competitors, taking institutional knowledge about protein folding and drug discovery to organizations building competing AI systems.
• Organizational Restructuring: Rather than maintaining AlphaFold as a standalone achievement, DeepMind is integrating its work into broader AI research initiatives, signaling a shift in how the lab prioritizes resources and talent allocation.

The kindest interpretation is that AlphaFold simply did its job. It solved its problem, spun off a company, and freed its people for the next thing. DeepMind says it remains "incredibly proud" of the work. The harder reading is what the shift signals: the lab most defined by deep science is reorganizing around the same language-model race as everyone else. Worse, it is losing the talent that made its name to the rivals driving that race.

Betting on an "AI scientist" powered by large language models is a bigger, vaguer goal than folding a protein. Whether this new approach pays off like AlphaFold did remains an open question. The departure of Nobel-winning researchers to Anthropic, a company explicitly focused on AI safety and capability research, underscores the tension between DeepMind's historical identity as a pure-science lab and its current role as part of Google's broader AI strategy.